Clinical trial
Flexible Dosed Duloxetine Versus Placebo in the Treatment of Fibromyalgia
NCT00673452 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Flexible Dosed Duloxetine Versus Placebo in the Treatment of Fibromyalgia
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- July 31, 2009
- Enrollment
- 530 (actual)
- Sites
- 46
Conditions
As the registry lists them; a condition with its own page is linked.